How serious is FDA warning about revolutionary blood-cancer treatment?— Harvard Gazette

Dana-Farber Cancer Institute researcher details promise, peril of CAR T-cell therapy, which enlists body’s immune system to fight disease.

Mark Flower on LinkedIn: Home

Mark Flower on LinkedIn: Kite releases pivotal CAR T therapy Phase III study results

Natasha Hansjee on LinkedIn: Artificial intelligence finds ways to develop new drugs

James Wang, PhD on LinkedIn: Porton Advanced and Ascle Therapeutics Reached a Strategic Partnership to…

How serious is FDA warning about revolutionary blood-cancer treatment?— Harvard Gazette

Byung-Soo Youn on LinkedIn: ONG41008 & BAXOTEGRAST

Mark Flower on LinkedIn: FDA approves Novartis Kymriah® CAR-T cell therapy for adult patients with…

Jason King on LinkedIn: Home

Mohammad Rashidian (@m_rashidian1) / X